Skip to content
naulon
Not checkedNot checked for notices yet.

Indications and prognostic outcome of inferior vena cava filter: Almoosa Hospital’s experience

Safwat A.M. Eldaboosy, Mahmoud Farouk, Abdullah Farouk and 4 more

Egyptian Journal of Chest Disease and Tuberculosis · 2022

doi:10.4103/ecdt.ecdt_42_21 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Background An inferior vena cava (IVC) filter is useful in patients with venous thromboembolism (VTE) who have any of the following conditions: contraindications to anticoagulants, recurrent pulmonary embolism (PE) despite anticoagulants or complications related to anticoagulants, and low cardiopulmonary reserve. This study aimed to assess indications, efficacy, and outcome of IVC filter insertion for patients with VTE. Patients and methods A retrospective study was conducted at Almoosa Hospital, Al Alhsa, Kingdom of Saudi Arabia, in the period between August 2017 and September 2020. All adult patients who underwent IVC filter were included. Results The study included 1350 cases. The patients were divided into two groups: group 1 included 1310 patients who had VTE without the need for an IVC filter, and group 2 included 40 patients, 39 of whom had VTE and required an IVC filter, and one patient with polytrauma (cerebral hemorrhage, pelvic hematoma) in whom an IVC filter was used prophylactically. A total of 40 IVC filters were used. Thirty (75%) patients had submassive PE with pulmonary hypertension and low pulmonary vascular reserve, nine (22.5%) patients had VTE with contraindications for an anticoagulant (due to gastrointestinal bleeding, cerebral hemorrhage, or major trauma), while one (2.5%) patient had an IVC filter inserted prophylactically although no VTE was present. The rate of IVC removal was 30% (12 cases), with no reported complications of IVC insertion or removal, except in one case where the filter was removed in two separate sessions. Conclusion IVC filter insertion, when used correctly, is a safe and effective method of preventing a potentially fatal PE by blocking the passage of thrombi from the lower extremities and pelvis to the lungs when used correctly.

Abstract licence: CC BY-NC-SA

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.